Stay updated on Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 is shown on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedTwo new publications are added under Publications, citing Lancet Oncology papers on tiragolumab plus atezolizumab with chemotherapy for unresectable or metastatic esophageal cancer; the items appear to be auto-filled from PubMed.SummaryDifference0.2%

- Check25 days agoChange DetectedAdded a new footer revision label: Revision: v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision tag updated from v3.2.0 to v3.3.2; no impact on study details, eligibility criteria, or trial data is evident from the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedLocation listings updated: added Tainan, Taiwan, 00704 and removed Tainan City, Taiwan, 00704. A funding-status notice banner was removed.SummaryDifference0.3%

- Check75 days agoChange DetectedThe page now shows the study status as Completed and lists 64 locations, with several sites removed. The Last Update Posted field is now shown as Estimated.SummaryDifference0.8%

Stay in the know with updates to Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.